Immatics (IMTX) Minority Interest (2019 - 2020)

Immatics (IMTX) reported Minority Interest of $559541.7 for Q2 2020, down 50.44% sequentially from $1.1 million in Q4 2019.

Immatics (IMTX) Minority Interest (2019 - 2020) Analysis & Trends

Immatics (IMTX) has 2 years of Minority Interest data on file, last reported at $559541.7 in Q2 2020.

For the quarter ending Q2 2020, Minority Interest changed N/A year-over-year to $559541.7; the trailing twelve-month figure through Jun 2020 stood at $559541.7 (changed N/A YoY), and the FY2019 full-year result was $1.1 million, changed N/A from the prior year.
Minority Interest eased to $559541.7 in Q2 2020, from $1.1 million in the prior quarter.
In the past five years, Minority Interest ranged from a high of $1.1 million in Q4 2019 to a low of $559541.7 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Immatics	1.11 Bn	1.11 Bn	-

Download Data

Date	Value
Jun 30, 2020	559,541.75
Dec 31, 2019	1.13 Mn